Topoisomerase ii-mediated DNA damage is differently repaired during the cell cycle by non-homologous end joining and homologous recombination

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-13

  de Campos Nebel, Marcelo ^a   Larripa, Irene ^a   González Cid, Marcela ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; GAMMA HISTONE H2AX; HISTONE H2AX; IDARUBICIN; RAD51 PROTEIN; SERINE; UNCLASSIFIED DRUG; VANILLIN; WORTMANNIN; DNA BINDING PROTEIN; RAD51C PROTEIN, HUMAN;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CELL ACTIVATION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY TEST; DNA DAMAGE; DNA RECOMBINATION; DNA REPAIR; DNA SYNTHESIS INHIBITION; HUMAN; HUMAN CELL; MICRONUCLEUS; NONHUMAN; PHENOTYPE; SISTER CHROMATID EXCHANGE; ANIMAL; CELL LINE; CRICETULUS; DOUBLE STRANDED DNA BREAK; GENETIC RECOMBINATION; GENETICS; HAMSTER; METABOLISM;

CRICETULUS GRISEUS;

ANIMALS; CELL CYCLE; CELL LINE; CRICETINAE; CRICETULUS; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; DNA REPAIR; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; HUMANS; RECOMBINATION, GENETIC;

EID: 77958551737     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012541     Document Type: Article

References (57)

1. Khanna KK, Jackson SP (2001) DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genetics 27: 247-254.
2. Deweese JE, Osheroff N (2009) The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing. Nucleic Acids Res 37: 738-748.
3. Wang JC (1996) DNA topoisomerases. Annu Rev Biochem 65: 635-692.
4. Warburton PE, Earnshaw WC (1997) Untangling the role of DNA Topoisom-erase II in mitotic chromosome structure and function. Bioessays 19: 97-99.
5. Wang JC (2002) Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol 3: 430-440.
6. Sakaguchi A, Kikuchi A (2004) Functional compatibility between isoform alpha and beta of type II DNA topoisomerase. J Cell Sci 117: 1047-1054.
7. Grue P, Grasser A, Sehested M, Jensen PB, Uhse A, et al. (1998) Essential mitotic functions of DNA topoisomerase IIa are not adopted by topoisomerase IIb in human H69 cells. J Biol Chem 273: 33660-33666.
8. Ju BG, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, et al. (2006) A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science 312: 1798-1802.
9. Lyu YL, Lin CP, Azarova AM, Cai L, Wang JC, et al. (2006) Role of topoisomerase IIbeta in the expression of developmentally regulated genes. Mol Cell Biol 26: 7929-7941.
10. Kimura K, Saijo M, Ui M, Enomoto T (1994) Growth state- and cell cycle-dependent fluctuation in the expression of two forms of DNA topoisomerase II and possible specific modification of the higher molecular weight form in the M phase. J Biol Chem 369: 1173-1176.
11. Austin CA, Marsh KL (1998) Eucaryotic DNA Topoisomerase II beta. Bioessays 20: 215-226.
12. Turley H, Comley M, Houlbrook S, Nozaki N, Kikuchi A, et al. (1997) The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues. Br J Cancer 75: 1340-1346.
13. Bigioni M, Zunino F, Capranico G (1994) Base Mutation Analysis of topoisomerase II-idarubicin-DNA ternary complex formation. Evidence for enzyme subunit cooperativity in DNA cleavage. Nucleic Acids Res 22: 2274-2281.
14. Burden DA, Kingma PS, Froelich-Ammon SJ, Bjornsti MA, Patchan MW (1996) Topoisomerase II. Etoposide interactions direct the formation of drug-induced enzyme-DNA cleavage complexes. J Biol Chem 271: 29238-29244.
15. Mao Y, Desai SD, Ting CY, Hwang J, Liu LF (2001) 26 S proteasome-mediated degradation of topoisomerase II cleavable complexes. J Biol Chem 276: 40652-40658.
16. Lieber MR (2008) The mechanism of human nonhomologous DNA end joining. J Biol Chem 283: 1-5.
17. Calsou P, Delteil C, Frit P, Drouet J, Salles B (2003) Coordinated assembly of Ku and p460 subunits of the DNA-dependent protein kinase on DNA ends is necessary for XRCC4-ligase IV recruitment. J Mol Biol 326: 93-103.
18. Ahnesorg P, Smith P, Jackson SP (2006) XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 124: 301-313.
19. Buck D, Malivert L, de Chasseval R, Barraud A, Fondaneche MC, et al. (2006) Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124: 287-299.
20. Chan DW, Chen BP, Prithivirajsingh S, Kurimasa A, Story MD, et al. (2002) Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes Dev 15: 2333-2338.
21. Uematsu N, Weterings E, Yano K, Morotomi-Yano K, Jakob B, et al. (2005) Autophosphorylation of DNA-dependent protein kinase regulates DNA end processing and may also alter double-strand break repair pathway choice. Mol Cell Biol 25: 10842-10852.
22. Chen BP, Chan DW, Kobayashi J, Burma S, Asaithamby A, et al. (2005) Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks. J Biol Chem 280: 14709-14715.
23. Uematsu N, Weterings EC, Yano K, Morotomi-Yano K, Jakob B, et al. (2007) Autophosphorylation of DNA-PKCS regulates its dynamics at DNA double-strand breaks, J Cell Biol 177: 219-229.
24. Rassool FV (2003) DNA double strand breaks (DSB) and non-homologous end joining (NHEJ) pathways in human leukemia. Cancer Lett 193: 1-9.
25. Maser RS, Monsen KJ, Nelms BE, Petrini JHJ (1997) hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol Cell Biol 17: 6087-6096.
26. Sigurdsson S, Van Komen S, Bussen W, Schild D, Albala JS, et al. (2001) Mediator function of the human Rad51B-Rad51C complex in Rad51/RPA-catalyzed DNA strand exchange. Genes Dev 15: 3308-3318.
27. Agarwal S, Tafel AA, Kanaar R (2006) DNA double-strand break repair and chromosome translocations. DNA Repair 5: 1075-1081.
28. Helleday T, Lo J, Van Gent DC, Engelward BP (2007) DNA double-strand break repair: From mechanistic understanding to cancer treatment. DNA Repair 6: 923-935.
29. Felix CA, Kolaris CP, Osheroff N (2006) Topoisomerase II and the etiology of chromosomal translocations. DNA Repair 5: 1093-1108.
30. Azarova AM, Lyu YL, Lin CP, Tsai YC, Lau JY, et al. (2007) From the cover: roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. Proc Natl Acad Sci USA 104: 11014-11019.
31. Malik M, Nitiss KC, Enriquez-Rios V, Nitiss JL (2006) Roles of nonhomologous end-joining pathways in surviving topoisomerase II-mediated DNA damage. Mol Cancer Ther 5: 1405-1414.
32. Adachi N, Suzuki H, Iiizumi S, Koyama H (2003) Hypersensitivity of Nonhomologous DNA End-joining Mutants to VP-16 and ICRF-193. J Biol Chem 278: 35897-35902.
33. Caldecott K, Banks G, Jeggo P (1990) DNA double-strand break repair pathways and cellular tolerance to inhibitors of topoisomerase II. Cancer Res 50: 5778-5783.
34. Sonoda E, Sasaki M, Morrison C, Yamaguchi-Iwai Y, Takata M, et al. (1999) Sister chromatid exchanges are mediated by homologous recombination in vertebrate cells. Mol Cell Biol 19: 5166-5169.
35. Hendrickson EA (1997) Cell-cycle regulation of mammalian DNA double-strand-break repair. Am J Hum Genet 61: 795-800.
36. Takata M, Sasaki MS, Sonoda E, Morrison C, Hashimoto M, et al. (1998) Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J 17: 5497-5508.
37. Haaf T, Raderschall E, Reddy G, Ward DC, Radding CM, et al. (1999) Sequestration of mammalian Rad51-recombination protein into micronuclei. J Cell Biol 144: 11-20.
38. Raderschall E, Bazarov A, Cao J, Lurz R, Smith A, et al. (2002) Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis. J Cell Sci 115: 153-164.
39. Mukherjee B, Kessinger C, Kobayashi J, Chen BP, Chen DJ, et al. (2006) DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells. DNA Repair 5: 575-590.
40. Imyanitov EN, Moiseyenko VM (2007) Molecular-based choice of cancer therapy: Realities and expectations. Clin Chim Acta 379: 1-13.
41. Fan JR, Peng AL, Chen HC, Lo SC, Huang TH, et al. (2008) Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses. DNA Repair 7: 452-463.
42. Burquess DJ, Doles J, Zender L, Xue W, Ma B, et al. (2008) Topoisomerase levels determine chemotherapy response in vitro and in vivo. Proc Natl Acad Sci USA 105: 9053-9058.
43. Toyoda E, Kagaya S, Cowell IG, Kurosawa A, Kamoshita K, et al. (2008) NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform. J Biol Chem 283: 23711-23720.
44. Jensen LH, Dejligbjerg M, Hansen LT, Grauslund M, Jensen PB, et al. (2004) Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells. BMC Pharmacol 4: 31.
45. Adachi N, Iiizumi S, So S, Koyama H (2004) Genetic evidence for involvement of two distinct nonhomologous end-joining pathways in repair of topoisomerase II-mediated DNA damage. Biochem Biophys Res Commun 318: 856-861.
46. Lieber MR, Hesse JE, Lewis S, Bosma GC, Rosenberg N, et al. (1988) The defect in murine severe combined immune deficiency: Joining of signal sequences but not coding segments in V(D)J recombination. Cell 55: 7-16.
47. Roth DB, Menetski JP, Nakajima P, Bosma MJ, Gellert M (1992) V(D)J recombination: Broken DNA molecules with covalently sealed (hairpin) coding ends in SCID mouse thymocytes. Cell 70: 983-991.
48. Schonn I, Hennesen J, Dartsch DC (2010) Cellular responses to etoposide: cell death despite cell cycle arrest and repair of DNA damage. Apoptosis 15: 162-172.
49. Treszezamsky AD, Kachnic LA, Feng Z, Zhang J, Tokadjian C, et al. (2007) BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II. Cancer Res 67: 7078-7081.
50. Adachi N, Iiizumi S, Koyama H (2005) Evidence for a role of vertebrate Rad52 in the repair of topoisomerase II-mediated DNA damage. DNA Cell Biol 24: 388-393.
51. Rothkamm K, Kruger I, Thompson LH, Lobrich M (2003) Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol 23: 5706-5715.
52. Mao Z, Bozzella M, Seluanov A, Gorbunova V (2008) DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells. Cell Cycle 7: 2902-2906.
53. Betti CJ, Villalobos MJ, Diaz MO, Vaughan AT (2001) Apoptotic triggers initiate translocations within the MLL gene involving the nonhomologous end joining repair system. Cancer Res 61: 4550-4555.
54. Betti CJ, Villalobos MJ, Diaz MO, Vaughan AT (2003) Apoptotic stimuli initiate MLL-AF9 translocations that are transcribed in cells capable of division. Cancer Res 63: 1377-1381.
55. Angelis KJ, Dusinská M, Collins AR (1999) Single cell gel electrophoresis: detection of DNA damage at different levels of sensitivity. Electrophoresis 20: 2133-2138.
56. Huang X, Okafuji M, Traganos F, Luther E, Holden E, et al. (2004) Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin. Cytometry A 58: 99-110.
57. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.